Adequate lung preservation for clinical lung transplantation: An important condition for satisfactory graft function

Journal of Cardiac Surgery

Volumn 15, Issue 2, 2000, Pages 141-148

  Görler, Adelheid ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELSIOR; EURO COLLINS SOLUTION; REACTIVE OXYGEN METABOLITE; UNIVERSITY OF WISCONSIN SOLUTION;

ACIDOSIS; ARTICLE; CELL METABOLISM; CLINICAL EXAMINATION; CLINICAL PRACTICE; GRAFT FAILURE; HUMAN; LUNG TRANSPLANTATION; MORTALITY; ORGAN PRESERVATION; RISK FACTOR; SURVIVAL;

GRAFT SURVIVAL; HUMANS; LUNG; LUNG TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS;

EID: 0034448213     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. 1. Hosenpud JD, Bennet LE, Keck BM, et al: The registry of the international society for heart and lung transplantation: Fifteenth official report - 1998. J Heart Lung Transplant 1998;17:656-668.
2. 2. Hosenpud JD, Bennet LE, Keck BM, et al: The registry of the international society for heart and lung transplantation: Fourteenth official report - 1997. J Heart Lung Transplant 1997;16:691-712.
3. 3. Hopkinson DN, Bhabra MS, Hooper TL: Pulmonary graft preservation: A woldwide survey of current clinical practice. J Heart Lung Transplant 1998;17: 525-531.
4. 4. Cooper JD, Vreim CE: Biology of lung preservation for transplantation. Am Rev Resp Dis 1992;146: 803-807.
5. 5. Kirk AJB, Colquhoun IW, Dark JH: Lung preservation: A review of current practice and future directions. Ann Thorac Surg 1993;56:990-1000.
6. 6. Haverich A, Scott WC, Jamieson SW: Twenty years of lung preservation. A review. Heart Transplant 1985;4:234-240.
7. 7. Novick RJ, Menkis AH, McKenzie FN: New trends in lung preservation: A collective review. J Heart Lung Transplant 1992;11:377-392.
8. 8. LeGal YM: Lung and heart-lung transplantation. Ann Thorac Surg 1990;49:840-844.
9. 9. Wahlers T, Haverich A, Fieguth HG, et al: Flush perfusion using Euro-Collins solution vs cooling by means of extracorporeal circulation in heart lung preservation. J Heart Transplant 1986;5:89-98.
10. 10. Wallwork J, Jones K, Cavarocchi N, et al: Distant procurement of organs for clinical heart-lung transplantation using a single-flush technique. Transplantation 1987;44:654-658.
11. 11. Haverich A, Wahlers T, Schäfers HJ, et al: Distant organ procurement in clinical lung-and heart-lung transplantation. Eur J Cardiothorac Surg 1990;4: 245-249.
12. 12. Hausen B, Beuke M, Schroeder F, et al: In vivo measurement of lung preservation solution efficacy: Comparision of LPD, UW, EC, and low-K-EC following short and extended ischemia. Eur J Cardiothorac Surg 1997;12:771-780.
13. 13. Albes JM, Brandes H, Heinemann MK, et al: Potassium-reduced lung preservation solutions: A screening study. Eur Surg Res 1997;29:327-338.
14. 14. Largiader F, Sturm A, Wicki O (eds): Organtransplantationen (in German). Georg Thieme Verlag, Stuttgart, Germany, 1996, pp. 18-22.
15. 15. Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 1988;45:673-676.
16. 16. Wu G, Zhang F, Salley RK, et al: A systematic study of hypothermic lung preservation solutions: EuroCollins solution. Ann Thorac Surg 1996;62:356-362.
17. 17. Hopkinson DN, Odom NJ, Bridgewater BJM, et al: Lung graft preservation. Transplantation 1994;58: 763-768.
18. 18. Love RB, Conhaim RL, Harms BA: Effects of University of Wisconsin and Euro-Collins solutions on interstitial pulmonary edema in isolated rat lungs. Transplantation 1996;61:1014-1018.
19. 19. Southard JH, Belzer FO: Organ preservation. Annu Rev Med 1995;46:235-247
20. 20. Kimblad PO, Sjöberg T, Massa G, et al: High potassium contents in organ preservation solutions cause strong pulmonary vasocontraction. Ann Thorac Surg 1991;52:523-528.
21. 21. Müller Ch, Hoffmann H, Kur F, et al: Der Einfluß von low potassium dextran (PerfadexR) auf den ischämie-reperfusionsschaden nach experimenteller und klinischer lungentransplantation (in German). Langenbecks Arch Chir 1999;1:635-640.
22. 22. Steen S, Kimblad PO, Sjöberg T, et al: Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg 1994;57:450-457.
23. 23. Ingemansson R, Massa G, Pandita RK, et al: Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function. Ann Thorac Surg 1995;60:1210-1214.
24. 24. Fokuse T, Hirata T, Ueda M, et al: Effects of EuroCollins, University of Wisconsin, and new extracellular-type trehalase-containing Kyoto solutions in an ex vivo rat lung preservation model. Transplantation 1996;62:1212-1217.
25. 25. Bando T, Albes JM, Nüsse T, et al: Comparison of Euro-Collins solution, low-potassium dextrane solution containing glucose, and ET-Kyoto solution for lung preservation in an extracorporeal rat lung perfusion model. Eur Surg Res 1998;30:297-304.
26. 26. Roberts RF, Nishanian GP, Carey JN, et al: A comparison of the new preservation solution Celsior to Euro-Collins and University of Wisconsin solutions in lung reperfusion injury. Transplantation 1999;67: 152-155.
27. 27. Fehrenbach A, Wittwer T, Cornelius J, et al: Improvement of rat lung structure and function after preservation with Celsior. J Surg Res 1999;82:285-293.
28. 28. Hooper TL, Thomson DS, Jones MT, et al: Amelioration of lung ischemic injury with prostacyclin. Transplantation 1990;49:1031-1035.
29. 29. Jurmann HJ, Dammenhayn L, Schäfers HJ, et al: Prostacyclin as an additive to single crystalloid flush: Improved pulmonary preservation in heart-lung transplantation. Transplant Proc 1987;19: 4103-4104.
30. 30. Novick RJ, Reid KR, Denning L, et al: Prolonged preservation of canine lung allografts: The role of prostaglandins. Ann Thorac Surg 1991;51:853-859.
31. 31. Hooper TL, Thomson DS, Jones MT et al: Modulation of ischemic lung injury by corticosteroids. Transplantation 1990;50:530-532.
32. 32. Hall TS, Borkon AM, Gurtner GC, et al: Improved static lung preservation with corticosteroids and hypothermia. J Heart Transplant 1988;7:348-352.
33. 33. Hachida M, Morton DL: The protection of ischemic lung with verapamil and hydralazine. J Thorac Cardiovasc Surg 1988;95:178-183.
34. 34. Hachida M, Morton DL: A new solution (UCLA formula) for lung preservation. J Thorac Cardiovasc Surg 1989;97:513-520.
35. 35. Karck M, Schmid C, Siclari F, et al: Effects of calcium channel blockage in postischemic lung perfusion. Transplant Proc 1990;22:2237.
36. 36. Hausen B, Rohde R, Hewitt CW, et al: Exogenous surfactant treatment before and after sixteen hours of ischemia in experimental lung transplantation. J Thorac Cardiovasc Surg 1997;113:1050-1058.
37. 37. Novick RJ, Gehman KE, Ali IS, et al: Lung preservation: The importance of endothelial and alveolar type II cells integrity. Ann Thorac Surg 1996;62: 302-314.
38. 38. Roberts RF, Nishanian GP, Carey JN, et al: Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury. Ann Thorac Surg 1998;66:225-230.
39. 39. Wang LS, Yoshikawa K, Miyoshi S, et al: The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg 1989;98:333-342.
40. 40. Wagner FM, Jamieson SW, Fung J, et al: A new concept for successful long-term pulmonary preservation in a dog model. Transplantation 1995; 59:1530-1536.
41. 41. Hausen B, Ramsamooj R, Hewitt CW, et al: The importance of static lung inflation during organ storage. Transplantation 1996;62:1720-1725.
42. 42. Sarsam MA, Yonan NA, Deiraniya AK, et al: Retrograde pulmonaryplegia for lung preservation in clinical transplantation: A new technique. J Heart Lung Transplant 1993;12:494-498.
43. 43. Ross SD, Tribble CG, Gaughen JR, et al: Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg 1999;67:1428-1433; Discussion 1434.
44. 44. Pillai R, Bando K, Schueler S, et al: Leukocyte depletion results in exellent heart-lung function after 12 hours of storage. Ann Thorac Surg 1990;50: 211-214.
45. 45. Tomizawa N, Ohwada S, Ohya T, et al: The effects of a neutrophil elastase inhibitor (ONO-5046.Na) and neutrophil depletion using a granulotrap (G-1) column on lung reperfusion injury in dogs. J Heart Lung Transplant 1999;18:637-645.
46. 46. Schueler S, De Valeria PA, Hatanaka M, et al: Successful twenty-four hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. J Thorac Cardiovasc Surg 1992;104:73-82.
47. 47. Breda MA, Hall TS, Stuart RS, et al: Twenty-four hour lung preservation by hypothermia and leukocyte depletion. Heart Transplant 1985;3: 325-329.
48. 48. Bando K, Schueler S, Cameron DE, et al: Twelve-hour cardiopulmonary bypass preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase. J Heart Lung Transplant 1991;10:304-309.
49. 49. Lindberg L, Sjöberg T, Ingemannson R, et al: Inhalation of nitric oxide after lung transplantation. Ann Thorac Surg 1996;61:956-962.
50. 50. Hausen B, Müller P, Bahra M, et al: Donor pre-treatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation. Transplantation 1996;62:1714-1719.
51. 51. Yano M, Mora BM, Ritter JM, et al: Ex vivo transfection of transforming growth factor-β1 gene to pulmonary artery segments in lung grafts. J Thorac Cardiovasc Surg 1999;117:705-713.